glp-1 drugs for weight loss cost Why payers are hesitant to cover The Heavy Cost of Using

Novo Nordisks Wegovy pill (oral semaglutide 25 mg, once daily) has just been approved by the US FDA as the first oral GLP1 receptor agonist for longterm weight management and CV risk reduction in people with overweight or obesity

The cost of Wegovy with insurance can sometimes be very cheap, and the drug maker estimates most people who have insurance coverage pay less than $25 per month

For patients currently on basal insulin or a GLP-1 RA : Start at 16 units subcutaneously once daily without regard to meals

Understanding the market and the cost-reduction strategies is key in this environment, researchers say

Its not a magic shot

Their primary indication is the management of type 2 diabetes, where they are used alongside diet and exercise to improve glycaemic control by enhancing insulin secretion, suppressing glucagon, and supporting healthier glucose regulation 3 , 4